Skip to main content
SpringerLink
Log in

Afatinib/erlotinib/gefitinib

Purpuric drug eruptions complicated to various infections: 32 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cho Y-T, et al. Purpuric drug eruptions caused by epidermal growth factor receptor inhibitors for non-small cell lung cancer: A clinicopathologic study of 32 cases. JAMA Dermatology 153: 906-910, No. 9, Sep 2017 - Taiwan

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib/erlotinib/gefitinib. Reactions Weekly 1676, 16 (2017). https://doi.org/10.1007/s40278-017-38004-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-38004-1

Search

Navigation